Bay­er drops $460M in­to con­tra­cep­tive man­u­fac­tur­ing sites with the Unit­ed Na­tion­s' back­ing

Bay­er will in­vest $460 mil­lion in­to two man­u­fac­tur­ing sites to ex­pand its pro­duc­tion ca­pa­bil­i­ties for con­tra­cep­tives to low- and mid­dle-in­come coun­tries.

Through a deal in­volv­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER